HomeCYCN • NASDAQ
add
Cyclerion Therapeutics Inc
Previous close
$1.38
Day range
$1.30 - $1.37
Year range
$1.28 - $6.25
Market cap
5.30M USD
Avg Volume
63.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 875.00K | 351.03% |
Operating expense | 1.53M | 23.53% |
Net income | -976.00K | -34.99% |
Net profit margin | -111.54 | 70.07% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.57M | 59.05% |
Total assets | 10.42M | 17.05% |
Total liabilities | 877.00K | 25.29% |
Total equity | 9.54M | — |
Shares outstanding | 3.81M | — |
Price to book | 0.53 | — |
Return on assets | -25.42% | — |
Return on capital | -27.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -976.00K | -34.99% |
Cash from operations | -264.00K | 84.62% |
Cash from investing | — | — |
Cash from financing | 1.83M | — |
Net change in cash | 1.56M | 191.03% |
Free cash flow | 83.25K | 104.90% |
About
Founded
2018
Website
Employees
1
